Allurion Technologies (NYSE:ALRN) focuses on innovative medical technologies that aim to tackle obesity and its associated health issues. As of now, the company is only listed on the New York Stock Exchange under the ticker symbol NYSE:ALRN, making it accessible to investors interested in the healthcare and technology sectors. Allurion is known for its flagship product, the Allurion Balloon, which is a swallowable and self-expelling gastric balloon that aids in weight loss without the need for surgery. By offering a non-surgical alternative, Allurion aims to revolutionize the approach to weight management and improve the quality of life for individuals struggling with obesity. The company's objectives revolve around expanding access to its technology globally while continuing to innovate in the field of non-invasive medical solutions for weight loss and beyond.